Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China
· Delayed Price · Currency is CNY 11.47
-0.05 (-0.43%)
Apr 29, 2026, 3:00 PM CST
SHA:600267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 540.71 | 601.18 | -93.17 | 488.86 | 486.89 | Upgrade
|
| Depreciation & Amortization | - | 973.1 | 1,087 | 1,048 | 1,040 | 951.73 | Upgrade
|
| Other Amortization | - | 8.48 | 3.43 | 3.26 | 5.59 | 6.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -5.23 | -0.72 | 11.49 | 2.06 | 46.71 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 75.77 | 4.12 | 193.21 | 0.57 | 2.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 34.51 | -162.92 | -72.1 | 1.02 | -87.75 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 50.56 | 86.75 | 23.48 | -9.53 | 12.7 | Upgrade
|
| Other Operating Activities | - | 284.72 | 372.46 | 343.48 | 487.51 | 482.38 | Upgrade
|
| Change in Accounts Receivable | - | 33.09 | 157.91 | 118.04 | -398.93 | -31.43 | Upgrade
|
| Change in Inventory | - | 66.09 | 69.13 | -170.73 | 19.03 | 398.83 | Upgrade
|
| Change in Accounts Payable | - | -59.35 | -47.68 | 167.61 | 362.18 | -585.72 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.51 | 5.99 | 9.15 | 46.7 | 20.26 | Upgrade
|
| Operating Cash Flow | - | 2,032 | 2,184 | 1,503 | 2,066 | 1,737 | Upgrade
|
| Operating Cash Flow Growth | - | -6.98% | 45.35% | -27.26% | 18.96% | 9.24% | Upgrade
|
| Capital Expenditures | - | -376.4 | -238.44 | -240.04 | -530.62 | -622.38 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 14.68 | 11.23 | 26.46 | 91.62 | 203.67 | Upgrade
|
| Divestitures | - | - | - | 23.1 | 43.45 | - | Upgrade
|
| Investment in Securities | - | -16.74 | 6.54 | -20.56 | -43.06 | -99.93 | Upgrade
|
| Other Investing Activities | - | 10.02 | -68.36 | -127.71 | -140.17 | 25.35 | Upgrade
|
| Investing Cash Flow | - | -369.1 | -290.36 | -338.71 | -578.78 | -493.28 | Upgrade
|
| Short-Term Debt Issued | - | - | 300 | - | 898.8 | 998.55 | Upgrade
|
| Long-Term Debt Issued | - | 2,358 | 4,092 | 3,831 | 4,606 | 6,649 | Upgrade
|
| Total Debt Issued | - | 2,358 | 4,392 | 3,831 | 5,504 | 7,647 | Upgrade
|
| Short-Term Debt Repaid | - | - | -304.04 | -608.54 | -813.27 | -508.63 | Upgrade
|
| Long-Term Debt Repaid | - | -3,580 | -5,798 | -3,786 | -6,216 | -8,912 | Upgrade
|
| Total Debt Repaid | - | -3,580 | -6,103 | -4,395 | -7,030 | -9,421 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1,222 | -1,710 | -564.17 | -1,525 | -1,773 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 23.29 | 922.14 | Upgrade
|
| Repurchase of Common Stock | - | -68 | -172.78 | -109.23 | -211.66 | -101.62 | Upgrade
|
| Common Dividends Paid | - | -343.42 | -148.47 | -356.3 | -381.25 | -417.3 | Upgrade
|
| Other Financing Activities | - | - | -5.25 | 25.49 | 589.57 | -703.79 | Upgrade
|
| Financing Cash Flow | - | -1,633 | -2,037 | -1,004 | -1,505 | -2,074 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.89 | 3.47 | 4.72 | 6.53 | -0.6 | Upgrade
|
| Net Cash Flow | - | 28.3 | -139.74 | 164.47 | -11.92 | -831.37 | Upgrade
|
| Free Cash Flow | - | 1,655 | 1,946 | 1,263 | 1,535 | 1,114 | Upgrade
|
| Free Cash Flow Growth | - | -14.92% | 54.10% | -17.75% | 37.78% | 24.13% | Upgrade
|
| Free Cash Flow Margin | - | 15.69% | 18.82% | 12.17% | 12.75% | 9.18% | Upgrade
|
| Free Cash Flow Per Share | - | 1.41 | 1.68 | 1.08 | 1.32 | 0.98 | Upgrade
|
| Cash Income Tax Paid | - | 805.55 | 626.07 | 643.89 | 666.43 | 667.02 | Upgrade
|
| Levered Free Cash Flow | - | 1,313 | 1,466 | 686.12 | 1,115 | 1,176 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,375 | 1,563 | 820.75 | 1,292 | 1,392 | Upgrade
|
| Change in Working Capital | - | 69.06 | 192.38 | 45.29 | 49.72 | -164.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.